The inflammation modulatory protein (IMP) of cowpox virus drastically diminishes the tissue damage by down-regulating cellular infiltration resulting from complement activation

Molecular and Cellular Biochemistry

Volumn 185, Issue 1-2, 1998, Pages 39-46

  Kotwal, Girish J ^a   Miller, Cathie G ^a   Justus, David E ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

C3; C5; Cowpox; IMP; In vivo model; Inflammation; Knockout mice; MIP 1 alpha

Indexed keywords

CHEMOKINE; INFLAMMATION MODULATORY PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COMPLEMENT ACTIVATION; CONNECTIVE TISSUE; CONTROLLED STUDY; COWPOX VIRUS; DERMIS; FOOT PAD; INFLAMMATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; TISSUE INJURY; VIRUS PATHOGENESIS; VIRUS RECOMBINANT;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C5; CONNECTIVE TISSUE; COWPOX VIRUS; DNA, RECOMBINANT; DNA, VIRAL; DOWN-REGULATION; FEMALE; GENE TARGETING; IMMUNITY, CELLULAR; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MODELS, BIOLOGICAL; VIRAL PROTEINS;

ANIMALIA; COWPOX VIRUS; POXVIRIDAE; VACCINIA; VACCINIA VIRUS; VARIOLA; VARIOLA VIRUS;

EID: 0031702845     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006844624825     Document Type: Article

References (27)

1. Miller CG, Shchelkunov SN, Kotwal GJ: Cowpox virus encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein (IMP). Virology 229: 126-133, 1997
2. Kotwal GJ: The great escape: Immune evasion by pathogens. Immunologist 4/5: 157-164, 1996
3. Moss B: In: BN Fields, DM Knipe and PM Howley (eds). Fundamental virology. Lipincott-Raven Press, Philadelphia, 1996, pp 1163-1198
4. Miller CG, Justus DE, Jayaraman S, Kotwal GJ: Severe and prolonged inflammatory response to localized cowpox virus infection in footpads of C5-Deficient mice: Investigation of the role of host complement in poxvirus pathogenesis. Cell Immunol 162: 326-332, 1995
5. Kotwal GJ, Moss B: Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily. J Virol 63: 600-696, 1989
6. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvesen GS, Pickup DJ: Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1 converting enzyme. Cell 69: 597-694, 1992
7. Kotwal GJ, Moss B: Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335: 176-178, 1988
8. Kotwal GJ, Hugin AW, and Moss B: Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein. Virology 282: 689-698, 1989
9. Upton C, Mossman K, and McFadden G: Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 258: 1369-1372, 1992
10. Massung RF, Esposito JJ, Liu L, Qi J, Utterback TR, Knight JC, Aubin L, Yuran TE, Parsons JM, Loparev VN, Selivanov NA, Cavallaro KF, Kerlavage AR, Mahy BWJ, Venter JC: Potential virulence determinants in terminal regions of variola smallpox virus genome. Nature 366: 748-751, 1993
11. Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B: Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250: 827-830, 1990
12. McKenzie R, Kotwal GJ, Moss B, Hammer CH, Frank MM: Regulation of complement activity by vaccinia virus complement-control protein. J Inf Dis 166: 1245-1254, 1992
13. Isaacs SN, Kotwal GJ, Moss B: Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc Natl Acad Sci USA 89: 628-632, 1992
14. Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O: Requirement of MIP-1 for an inflammatory response to viral infection. Science 269: 1583-1585, 1995
15. Li CY, Yam LT, Sun T: Modern modalities for the diagnosis of hematologic neoplasms, Igaku-Shoin, New York, 1996.
16. Kotwal GJ, Moss B: Analysis of a large cluster of nonessential genes deleted from a vaccinia virus terminal transposition mutant. Virology 167: 524-537, 1988
17. Palumbo GJ, Pickup DJ, Fredrickson TN, McIntyre LJ, Buller RML: Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus. Virology 172: 262-273, 1989
18. Spriggs MK, Armitage RJ, Comeau MR, Strockbine L, Farrah T, McDuf B, Ulrich D, Alderson MR, Mullberg J, Cohen, JI: The extracellular domain of the Epstein-Barr Virus BZLF2 protein binds the HLA-DR chain and inhibits antigen presentation. JVirol 70: 5557-5563, 1996
19. Kotwal GJ: Microorganisms and their interaction with the immune system. J Leukocyte Biol 62: 415-429, 1997
20. Spriggs MK, Hruby DE, Maliszewski CR, Sims JE, Buller RML, VanSlyke J: Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71: 145-152, 1992
21. Alcami A, Higbee NC, Smith GL: Poxvirus conference 103(Abstract), 1994
22. Palumbo GJ, Buller RML, Glasgow WC: Multigenic evasion of inflammation by poxviruses. J Virol 68(3): 1737-1749, 1994
23. Buller RML, Chakrabarti S, Moss B, Fredrickson TN: Cell proliferative response to vaccinia virus is mediated by VGF. Virology 164: 182-192, 1988
24. Graham KA, Lalani AS, Macen JL, Ness TL, Barry M, Liu L-Y, Lucas A, Clark-Lewis I, Moyer RW, McFadden G: The T1/35 kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229: 12-24, 1997
25. Miller CG, Wellhausen S, Justus DE, Kotwal GJ: In: E Faist (ed). Cowpox virus IMP modulates the inflammatory response by restricting mononuclear cell infiltration in proceedings of the 4th International Congress on The Immune Consequences of Trauma, Shock and Sepsis. Monduzzi Editore, Bologna, Italy, 1997, pp 209-213
26. Kotwal GJ, Blasco R, Miller CG, Kuntz S, Jayaraman S, Shchelkunov SN: Strategies for Immunomodulation and evasion by microbes: Important consideration in the development of live vaccine. In: MM Albl, HH Peter (eds). Symp Immunol VII: Vaccination. Springer-Verlag, Berlin, Heidelberg, 1998, in press
27. Miller CG, Cook DN, Kotwal GJ: Two chemotactic factors C5a and MIP-1 alpha, dramatically alter the mortality from zymosan-induced multiple organ dysfunction syndrome (MODS): C5a contributes to MODS while MIP-1 alpha has a protective role. Mol Immunol 33: 1135-1137, 1996